GlassScriptPhysician profile
Robert C Foster
NPI 1104323401
$2,931.03
in general payments reported to CMS, 2019-2025
9 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,997 · 2023: $389 · 2024: $88.93 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.90 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,926.46 | 2022-2025 | Luxor |
| Astellas Pharma US INC | $271.27 | 2023-2025 | Izervay |
| Genentech USA, INC. | $170.17 | 2023-2025 | Vabysmo |
| Harrow Eye, LLC | $151.40 | 2025 | |
| Genentech, INC. | $147.25 | 2022 | |
| Abbvie INC. | $110.25 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $99.99 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $30.81 | 2023 | Xipere |
| Sandoz INC. | $23.43 | 2024 | Cimerli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.